Pretransplant <i>FLT3</i>-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome
Sun Loo(Northern Health), Andrew H. Wei(The Royal Melbourne Hospital), Adam Ivey(The Alfred Hospital), Sean Johnson(Cardiff University), Ashish Bajel(The Royal Melbourne Hospital), Amanda Gilkes(Cardiff University), Ing Soo Tiong(The University of Melbourne), Manohursingh Runglall(King's College London), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Jad Othman(The University of Sydney), Zhi Han Yeoh(The Royal Melbourne Hospital), Natasha S. Anstee(The University of Melbourne), Ian Thomas(Cardiff University), David Ritchie(Peter MacCallum Cancer Centre), Nicola Potter(European Bioinformatics Institute), Chyn Chua Chong(Walter and Eliza Hall Institute of Medical Research), Michelle McBean(Peter MacCallum Cancer Centre), Richard Dillon(King's College London), Kelli Gray(The Royal Melbourne Hospital), Jelena Jovanović(Centre de Recherche Jean Pierre Aubert)
Cited by 83
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k